DIGITAL CENTRIC COMMERCIALIZATION Trademark

Trademark Overview

On Monday, March 1, 2021, a trademark application was filed for DIGITAL CENTRIC COMMERCIALIZATION with the United States Patent and Trademark Office. The USPTO has given the DIGITAL CENTRIC COMMERCIALIZATION trademark a serial number of 90552903. The federal status of this trademark filing is REGISTERED as of Tuesday, April 23, 2024. This trademark is owned by Axsome Therapeutics, Inc.. The DIGITAL CENTRIC COMMERCIALIZATION trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Consulting services in the field of health relating to pharmaceuticals; Providing health information relating to pharmaceuticals; Providing health information relating to pharmaceuticals via a website; Providing medical information relating to pharmaceuticals via a website; Providing news and information in the field of medicine relating to pharmaceuticals; Providing on-line information, news and commentary in the field of health and wellness relating to pharmaceuticals
digital centric commercialization

General Information

Serial Number90552903
Word MarkDIGITAL CENTRIC COMMERCIALIZATION
Filing DateMonday, March 1, 2021
Status700 - REGISTERED
Status DateTuesday, April 23, 2024
Registration Number7368987
Registration DateTuesday, April 23, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesConsulting services in the field of health relating to pharmaceuticals; Providing health information relating to pharmaceuticals; Providing health information relating to pharmaceuticals via a website; Providing medical information relating to pharmaceuticals via a website; Providing news and information in the field of medicine relating to pharmaceuticals; Providing on-line information, news and commentary in the field of health and wellness relating to pharmaceuticals

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, May 30, 2021
Primary Code044
First Use Anywhere DateWednesday, November 4, 2020
First Use In Commerce DateWednesday, November 4, 2020

Trademark Owner History

Party NameAxsome Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10007
Party NameAxsome Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10007

Trademark Events

Event DateEvent Description
Thursday, March 4, 2021NEW APPLICATION ENTERED
Sunday, May 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 13, 2021ASSIGNED TO EXAMINER
Wednesday, September 15, 2021NON-FINAL ACTION WRITTEN
Wednesday, September 15, 2021NON-FINAL ACTION E-MAILED
Wednesday, September 15, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 3, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 3, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 2, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 3, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 5, 2022NON-FINAL ACTION WRITTEN
Tuesday, April 5, 2022NON-FINAL ACTION E-MAILED
Tuesday, April 5, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 27, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 27, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 29, 2022TEAS AMENDMENT OF USE RECEIVED
Wednesday, October 26, 2022USE AMENDMENT ACCEPTED
Wednesday, October 26, 2022NON-FINAL ACTION WRITTEN
Wednesday, October 26, 2022NON-FINAL ACTION E-MAILED
Wednesday, October 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 27, 2022NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, April 25, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 8, 2023ASSIGNED TO LIE
Monday, September 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 11, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 12, 2023FINAL REFUSAL WRITTEN
Thursday, October 12, 2023FINAL REFUSAL E-MAILED
Thursday, October 12, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, January 5, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, January 5, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, January 24, 2024TEAS AMENDMENT OF USE RECEIVED
Wednesday, January 24, 2024USE AMENDMENT FILED
Friday, January 26, 2024AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, February 14, 2024USE AMENDMENT ACCEPTED
Thursday, February 15, 2024NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, March 19, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, March 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 20, 2024APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, April 23, 2024REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, April 23, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, May 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

commercialization centric digital relating pharmaceuticals providing information health field website news commentary wellness